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Objective: To investigate the role of vitamin D status in infantile
food allergy.
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Open access under CC BY-NC-ND license.on skin prick test and food challenge). Serum 25-
hydroxyvitamin D levels were measured by using liquid
chromatography tandem mass spectrometry. Associations
between serum 25-hydroxyvitamin D and food allergy were
examined by using multiple logistic regression, adjusting for
potential risk and confounding factors.
Results: Infants of Australian-born parents, but not of parents
born overseas, with vitamin D insufficiency (<_50 nmol/L) were
more likely to be peanut (adjusted odds ratio [aOR], 11.51; 95%
CI, 2.01-65.79; P 5 .006) and/or egg (aOR, 3.79; 95% CI, 1.19-
12.08; P 5 .025) allergic than were those with adequate vitamin
D levels independent of eczema status. Among those with
Australian-born parents, infants with vitamin D insufficiency
were more likely to have multiple food allergies (>_2) rather than
a single food allergy (aOR, 10.48; 95% CI, 1.60-68.61 vs aOR,
1.82; 95% CI, 0.38-8.77, respectively).
Conclusions: These results provide the first direct evidence that
vitamin D sufficiency may be an important protective factor for
food allergy in the first year of life. (J Allergy Clin Immunol
2013;131:1109-16.)
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Food allergy and food allergy–related anaphylaxis have in-
creased dramatically and inexplicably in the last two decades.1
Recent hypotheses that low vitamin D levels may increase the
risk of food allergy2 are supported by 2 lines of ecological
enquiry.
First, countries further from the equator (and thus with lower
ambient ultraviolet radiation [UVR]) have recorded more pedi-
atric admissions to hospitals for food allergy–related events3 and
more prescriptions for adrenaline autoinjectors for the treatment
of anaphylaxis in children.3,4 These findings appear to be inde-
pendent of longitude, physician density, or socioeconomic status.
Second, season of birth may play a role. For example, children at-
tending emergency departments in Boston with a food-related
acute allergic reaction weremore likely to be born in autumn/win-
ter, when vitamin D levels reach their nadir, than in spring/sum-
mer,5 and similar links of food allergy to birth seasonality were
reported in the Southern Hemisphere.6 However, these indirect
associations were not supported by direct serological measure-
ments of vitamin D status nor adjusted for numerous factors
that may confound or modify the association between vitamin
D status and food allergy.7 Prominent among these are ethnicity,8
skin color,9 and genotype.101109
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1110 ALLEN ET ALAbbreviations used25(OH)D: 25-Hydroxyvitamin DaOR: Adjusted odds ratioHREC: Human Research Ethics CommitteeOFC: Oral food challengeOR: Odds ratiosIgE: Specific IgESPT: Skin prick testUVR: Ultraviolet radiationMelbourne, the most southern major mainland city in Aus-
tralia, has the highest reported prevalence of documented infantile
food allergy in the world, with more than 10% of a population
sample of 1-year-old infants having challenge-proven IgE-medi-
ated food allergy.11 In a separate study population, we have shown
that children residing in Australia’s southern states have twice the
odds (95% CI, 1.2-5.0) of peanut allergy at the age of 4 to 5 years
and thrice the odds (95% CI, 1.0-9.0) of egg allergy than do those
residing in the northern states.12 In addition, we found that delay-
ing the introduction of egg, one of breast-fed infants’ richest sour-
ces of vitamin D in the first year of life, trebled the odds of
developing egg allergy by the age of 1 year (95% CI, 1.8-6.5).13
Finally, a rising prevalence of vitamin D insufficiency over the
last 20 years,14 with up to 30% of Melbourne pregnant women
now vitamin D insufficient,15 has paralleled the rise in food al-
lergy. Australia is one of the few developed countries where rou-
tine fortification of the food chain supply with vitamin D does not
occur.
By drawing on baseline data from the HealthNuts cohort study,
we aimed to examine the association between vitamin D insuf-
ficiency and food allergy in infants aged 12 to 18 months.METHODS
Design, participants, and procedures
HealthNuts is a large-scale, population-based cohort study undertaken to
assess the prevalence and risk factors for allergic disease in early child-
hood.11,13,16 Briefly, by using a predetermined population-based sampling
frame drawn from local government–led immunization clinics in Melbourne,
Australia (population 4 million), infants were recruited while attending
1-year-old immunization sessions at 1 of more than 120 locations. Recruit-
ment took place between September 2007 and August 2011. All infants
aged between 11 and 15 months (inclusive) and attending council-led immu-
nization sessions were eligible for recruitment (74% response rate). Reasons
for nonparticipation included eating and tolerating all foods (24.5%), testing
too painful for the child (18.0%), too busy (8.7%), parent did not speak English
(5.5%), and existing food allergy diagnosis (0.9%). The sample size of 5000
infants was calculated to provide sufficient power to detect risk factors present
in at least 10% of the population, given a prevalence of food sensitization or
allergy of 5% to 10%. Power calculations were performed by using simulation
studies based on the known prevalence of individual and household risk fac-
tors from the 5000-strong infant cohort in the Longitudinal Study of Australian
Children based on Wave 1 data collected in 2004 toward the end of the first
year of life. Given a risk factor prevalence of 10%, this sample size was cal-
culated to provide 84% power to detect an odds ratio (OR) of 1.75 by assuming
a prevalence of food allergy of 5% as well as 98% power to detect an OR of
1.75 by assuming a prevalence of food allergy of 10%.
Parents completed a questionnaire,16 and infants were skin prick tested to
hen’s egg, peanut, sesame, and either cow’s milk (n 5 2715) or shrimp
(n 5 2405) (ALK-Abello, Madrid, Spain), with a positive control (histamine
10 mg/mL) and a negative control (saline) using single-tine lancets on the in-
fant’s back. All infants were examined for the presence of eczema. Allparticipants with a detectable wheal to 1 or more foods, defined as 1 mm or
more bigger than the negative control, were invited to a Royal Children’s Hos-
pital–based clinic, where staff administered diagnostic oral food challenges
(OFCs), blinded to the infant’s skin prick test (SPT) wheal size and history of
ingestion (see Table E1 in this article’s Online Repository at www.jacionline.
org for challenge protocols).We chose any detectablewheal size as our entry cri-
terion to assess the food allergy status of participants to ensurewewere not miss-
ing any cases of potential food allergy. Repeat SPTs were undertaken at the time
of the OFC, and only those infants with both a positive food challenge by objec-
tive criteria and anSPTwheal size of 2mmormore or specific IgE (sIgE) level of
0.35 kUA/L ormorewere deemed food allergic. A random sample of infantswith
negative SPT results was also invited to undergo a food challenge (negative con-
trols for the clinic study sample). SPT was repeated at clinic attendance (6-8
weeks after the initial contact) by using an extended panel of foods: egg, peanut,
sesame, cow’s milk, shrimp, cashew, hazelnut, almond, wheat, and soy (ALK-
Abello). Blood sample for serum vitaminD and food-specific IgE to egg, peanut,
sesame, and cow’s milk or shrimp was obtained.
In a substudy, vitamin D supplementation, parents’ ethnicity, and skin type
were also assessed in a random subsample of infants (N5 350; see Table E4 in
this article’s Online Repository at www.jacionline.org) by using a graded skin
color chart shown to have excellent agreement with melanin density measured
with a spectrophotometer.17
Measures of outcome: Food allergy definitions
IgE-mediated allergy to egg, peanut, and sesame.
Positive OFC, that is, 1 or more than 1 of the following: 3 or more concurrent
noncontact urticaria lasting 5 minutes or more; perioral/periorbital angioe-
dema; vomiting; or circulatory or respiratory compromise within 2 hours of
ingestion of a challenge dose.16 Infants underwent OFC irrespective of their
history of ingestion or SPT wheal size unless there was a clear history of an
immediate reaction to the food in question (as per the HealthNuts challenge
criteria) within the past 1 month for egg or 2 months for peanut or sesame.
Only infants with a positive food challenge or recent reaction by these objec-
tive criteria and an SPTwheal size of 2mmormore or sIgE level of 0.35 kUA/L
or morewere deemed food allergic. Infants with an SPTwheal size of 8 mm or
more to one of the other foods (cashew, hazelnut, almond, wheat, soy, cow’s
milk, or shrimp) on the extended panel (n5 7) at the challenge clinic were pre-
sumed food allergic to that food.
Food-sensitized tolerant. SPTwheal size of 2 mm or more and/
or sIgE level of 0.35 kUA/L or more at the clinic to egg, peanut, or sesame and
negativeOFC. If sensitized tomore than 1 food, OFC results had to be negative
to all foods to which sensitization was present.
Non–food-sensitized tolerant. SPT wheal size of less than 2
mm and sIgE level of less than 0.35 kUA/L to all foods at the clinic in conjunc-
tion with a negative OFC to either peanut or egg. Infants with a positive OFC
despite a negative SPT (n5 11) were excluded from the analysis as their IgE-
mediated allergy status was unclear.
The current diagnosis of eczema at age 12 months was defined as either a
parent report of diagnosed eczema currently requiring medication or eczema
observed by a trained nurse at the time of recruitment.Measures of exposure: Vitamin D and UVR
Vitamin D status. Vitamin D deficiency: 25-hydroxyvitamin D3
(25(OH)D3) level of 25 nmol/L or less; vitamin D insufficiency: 25(OH)D3
level of 26 to 50 nmol/L; vitamin D sufficient: 25(OH)D3 level of more than
50 nmol/L.18 Serum 25(OH)D3 level was measured in 2 batches by using
liquid chromatography tandem mass spectrometry at the Royal Melbourne
Institute of Technology. Extracts were derivatized with 4-phenyl-1,2,4-
triazoline-3,5-dione prior to analysis with liquid chromatography tandem
mass spectrometry. This laboratory has previously demonstrated high
interbatch agreement for duplicate samples (n 5 39 pairs; intraclass
correlation 5 0.89).17 We fitted a sinusoidal curve to data on 25(OH)D3
levels19 and the date of blood sampling and took the difference between ob-
served and fitted vitamin D levels (ie, the regression residual) to represent a
seasonally adjusted measure of vitamin D.
TABLE I. Characteristics of HealthNuts infants by food allergy outcome
Characteristic
All infants who were
nonallergic to food
(n 5 3794)
Infants included in the current analysis (%)*
Infants who were
nonallergic and attended
clinic (n 5 207)
Infants who
were allergic
to food (n 5 274)
Family characteristics
Family history of allergic disease 68.9 76.1 75.1
Family history of eczema 29.4 37.1 38.0
Family history of food allergy 13.0 19.3 12.4
Both parents born in Australia 62.5 68.1 47.8
Maternal smoking during pregnancy 4.7 3.8 3.0
Maternal multivitamin use during pregnancy (without
additional vitamin D)
74.0 78.9 75.5
Maternal vitamin D use during pregnancy 5.3 7.2 4.2
Any siblings 50.6 56.8 47.1
Infant characteristics
Sex: male 50.0 49.8 59.9
Current eczema (at 12 mo) 21.1 29.2 52.6
History of eczema diagnosis (by age 12 mo) 20.1 31.5 57.8
Ever breast-fed 94.2 96.7 94.9
Ever used infant formula 78.9 72.8 77.4
Ever consumed egg 97.0 95.8 92.0
Vitamin D supplement in infancy – 14.5 7.5
Vitamin D insufficiency (26-50 nmol/L) – 16.4 17.9
Vitamin D deficiency (<_25 nmol/L) – 1.4 6.3
*Restricted to those infants with both vitamin D results available and food allergy status known (see Fig E1) and who also had complete data on all the characteristics captured in
this table.
Asthma, allergic rhinitis, eczema, or food allergy.
The most commonly used multivitamin supplements taken during pregnancy in this cohort were Blackmores and Elevit pregnancy supplements containing 6.3 and 12.5 mg
vitamin D3 per capsule, respectively.
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ambient daily UVR for the month in which the child was born by using
Australian Radiation Protection and Nuclear Safety Agency data for
Melbourne’s monthly average daily total UVR dose in standard erythemal
doses from 2007 to 2012.
Socioeconomic status was assigned on the basis of home postcode by using
Socio-Economic Indexes for Areas (SEIFA) measures derived from the 2006
Australian census, which assess relative socioeconomic advantage/disadvan-
tage, economic resources (income, assets, and expenditure), and educational
and occupational characteristics.20Statistical analysis
The variation in vitamin D levels attributable to a single risk factor was
quantified by calculating the proportional reduction in the residual sum of
squares (ie, R2) from simple linear regressionmodels.We used amultivariable
logistic regressionmodel to estimate ORs and thus quantify the association be-
tween vitamin D levels and the odds of food allergy. The current use of infant
formula (none, formulawith continued breast-feeding, and formula alone) and
history of egg consumption (none, baked goods containing egg [eg, cakes and
biscuits], cooked egg [eg, scrambled or soft boiled egg] on 1 occasion, and
cooked egg on multiple occasions) were both selected a priori for inclusion
in the final model, as both are dietary sources of vitamin D and associated
with the odds of infant food allergy.13,21 Other potential confounders (infant
history of eczema, age [in months] at OFC, infant’s sex, duration of breast-
feeding, infant consumption of fish [yes/no], number of siblings, socioeco-
nomic status, pet ownership, maternal use of vitamin D supplements during
pregnancy, maternal smoking during pregnancy, family history of allergy, fil-
aggrin null mutations, season of birth, and UVR at the month of birth) were
retained in the regression model only if their inclusion caused a more than
10% change in the magnitude of the association between vitamin D status
and the odds of food allergy. Nested models for 2 sample comparisons of pro-
portions (those with or without a binary exposure, those with and without in-
teraction terms, or those with different representations of the same exposure
variable) were compared by using the likelihood ratio test.On the basis of a priori decisions, analyseswere stratified for parental birth-
place (ie, both parents born in Australia) as a proxy for fairer skin. In the sub-
study (see Table E4), 93% of the infants of Australian-born parents and 51%of
the infants of non–Australian-born parents had fair or medium-fair skin. Of in-
fants whowere dark or olive-skinned, 92%had a parent born overseas.We also
conducted subgroup analyses on the sensitized group only,22 dichotomizing as
food allergic versus tolerant.
To mitigate bias in estimated ORs due to low attendance fraction at the
clinic for infants whowere nonsensitized, we generated weights as the inverse
of the probability of clinic attendance for all infants who were nonsensitized
within groups defined by cross-classifying family history of food allergy,
infant history of eczema, and parents’ country of birth23 (see this article’s On-
line Repository available at www.jacionline.org). These weights were used in
the corresponding logistic regression models, with robust standard errors used
to ensure that the precision of estimated ORs reflected the sample size.
Analyses were performed by using Stata (version 11.1, College Station,
Tex).Ethics
Ethical approval was obtained from the Office for Children Human
Research Ethics Committee (HREC; ref no CDF/07/492), Department of
Human Services HREC (ref no 10/07), and Royal Children’s Hospital HREC
(ref no 27047).RESULTS
Between September 28, 2007, and August 10, 2011, 7134
eligible parents/guardians were approached and 5276 (average
age, 12.7 6 0.7 months) agreed to participate. Of these, 5120
infants completed an SPT and 1089 (21%) had a positive SPT to
1 or more of the 4 foods tested (see Fig E1 in this article’s Online
Repository available at www.jacionline.org). Of these, 928 (85%)
attended the OFC clinic at the age of 14 to 18 months along with
TABLE II. Association between vitamin D insufficiency (<_50 nmol/L) and food allergy and/or eczema
Outcome and stratification variables OR (95% CI) P value aOR (95% CI)* P value
Association between vitamin D and any food allergy
Among all infants (n 5 481)
No food allergy (n 5 207) 1.0 1.0
Any food allergy (n 5 274) 1.38 (0.88-2.17) .16 1.29 (0.51-3.25) .59
Among infants with 1 or both parents born overseas (n 5 210)
No food allergy (n 5 67) 1.0 1.0
Any food allergy (n 5 143) 0.73 (0.38-1.41) .35 0.39 (0.08-1.76) .22
Among infants with both parents born in Australia (n 5 271)
No food allergy (n 5 140) 1.0 1.0
Any food allergy (n 5 131) 2.14 (1.15-4.00) .017 3.08 (1.10-8.59) .032
Association between vitamin D and specific food allergies among infants with both parents born in Australia
No food allergy (n 5 140) 1.0 1.0
Single food (n 5 96) 2.40 (1.07-5.42) .035 1.82 (0.38-8.77) .46
Multiple foods (n 5 32) 5.67 (2.26-14.28) <.001 10.48 (1.60-68.61) .014
No food allergy (n 5 140) 1.0 1.0
Egg allergy (n 5 110) 3.36 (1.56-7.22) .002 3.79 (1.19-12.08) .025
No food allergy (n 5 140) 1.0 1.0
Peanut allergy (n 5 33) 3.11 (1.17-8.23) .023 11.51 (2.01-65.79) .006
Association between vitamin D and eczema§
Among all infants (n 5 481)
No eczema (n 5 166) 1.0
History of eczema (n 5 103) 1.22 (0.68-2.17) .50 0.50 (0.09-2.66) .42
Current eczema (n 5 174) 0.98 (0.58-1.64) .92 1.34 (0.37-4.79) .66
Among infants with both parents born in Australia (n 5 271)
No eczema (n 5 103) 1.0 1.0
History of eczema (n 5 56) 1.29 (0.57-2.91) .54 1.09 (0.11-10.76) .94
Current eczema (n 5 99) 1.27 (0.63-2.56) .50 2.19 (0.28-16.92) .45
Among infants with 1 or both parents born overseas (n 5 210)
No eczema (n 5 63) 1.0 1.0
History of eczema (n 5 47) 1.06 (0.46-2.43) .89 0.21 (0.03-1.45) .11
Current eczema (n 5 75) 0.68 (0.31-1.47) .33 1.04 (0.18-6.21) .96
*The adjusted analysis controlled for date of blood draw, current use of infant formula (classified as none, formula with continued breast-feeding, and formula alone), and history of
egg consumption (classified as none, baked goods containing egg, cooked egg on 1 occasion, and cooked egg on multiple occasions), and mothers’ country of birth (for those born
outside Australia). Food allergy outcomes were adjusted for the current eczema status, and eczema outcomes were adjusted for food allergy. Adjustment for socioeconomic status,
sex, age at OFC clinic attendance, infant consumption of fish, number of siblings, family history of allergy, maternal use of vitamin D supplements during pregnancy, dog
ownership, and maternal smoking—each changed the magnitude of the association between low vitamin D status and food allergy by <10%; thus, these variables were not included
in the final model. To mitigate bias in estimated ORs owing to the low attendance fraction at the clinic for infants who were nonsensitized, the final model also included the use of
sampling weights defined as the inverse of the probability of clinic attendance for all infants who were nonsensitized within groups defined by cross-classifying family history of
food allergy, infant history of eczema, and parents’ country of birth.
This analysis was additionally adjusted for parents’ country of birth. Difference in effect for food allergy by parents’ country of birth in the adjusted model (P5 .003). Difference
in effect for eczema by parents’ country of birth in the adjusted model (P 5 .40 for current eczema; P 5 .18 for history of eczema).
Three infants who were allergic to food were excluded from the analysis of single versus multiple food sensitization because of missing food allergy status data for 1 or more
foods to which they were sensitized. The number of infants included in the egg- and peanut-specific food allergy analysis does not add up to the total; for example, the egg allergy
analysis compared only infants with no food allergies to infants with egg allergy. Infants allergic to peanut but not egg were not included in this analysis.
§Thirty-eight infants had missing data on eczema status and were excluded from this analysis.
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blood sample for vitamin D testing, and food allergy status could
be determined for 577 of these (see Fig E1 for inconclusive food
allergy classifications). Complete data on confounders were avail-
able for 481 (83%) of the 577 infants with known vitamin D and
food allergy status. All analyses were restricted to the 481 infants
with complete information on vitamin D, food allergy, and con-
founders. Table I shows characteristics of these 481 infants com-
pared with those of the whole study population. Table E3 in this
article’s Online Repository at www.jacionline.org compares char-
acteristics of infants with and without blood samples available.Serum vitamin D (25(OH)D3) levels in infants at the
age of 14 to 18 months
Infants with both parents born in Australia had a significantly
higher mean vitamin D level than did those without (meandifference, 7.61 units; 95%CI, 3.19-12.04; P <.001; see Fig E2 in
this article’s Online Repository available at www.jacionline.org).
Ambient UVR levels 6 weeks prior to blood draw accounted for
only 10% and 9% of the variation in serum vitamin D levels
among infants of Australian- and non–Australian-born parents,
respectively. Ambient UVR levels at the time of birth explained
even less of the variation in serum 25(OH)D levels. Among in-
fants of Australian- and non–Australian-born parents, the use of
infant formula accounted for 4.6% and 10.5 % and the consump-
tion of egg 0.8% and 0.7% of the variation in vitamin D levels,
respectively.Association between serum vitamin D levels and
food allergy and/or eczema
Parents’ country of birth was the only variable investigated that
modified the association between vitamin D and food allergy
FIG 1. Prevalence of vitamin D insufficiency (open bar, <_50 nmol/L) and deficiency (solid bar, <_25 nmol/L)
among various food allergy phenotypes (A) and food allergy with and without eczema among infants
with both parents born in Australia (B). Compared with infants with neither eczema nor food allergy, vitamin
D insufficiency was significantly more common in infants with food allergy with or without eczema (P < .005
for both comparisons) but not in infants with eczema alone (P 5 .87). Vitamin D insufficiency was also sig-
nificantly more common among infants with 2 or more food allergies compared with infants with 1 food
allergy (P 5 .045).
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parents, those with vitamin D insufficiency were more likely to
be food allergic. This association was not evident for infants of
parents born outside of Australia (Table II). The prevalence of
both vitamin D deficiency and insufficiency was higher in all in-
fants with any type of food allergy but not in those with eczema
alone (Fig 1).We found no evidence that vitamin D levels in quin-
tiles compared with a binary variable for vitamin D insufficiency
(cut point 50 nmol/L) provided a better model for the prevalence
of food allergy (P5 .24 and .28 for infants of parents born in Aus-
tralia and outside Australia, respectively), and so the latter repre-
sentation was retained.
Adjusting for date of blood draw strengthened themagnitude of
the association between vitamin D and food allergy among
Australian-born infants (adjusted odds ratio [aOR], 3.21; 95%
CI, 1.21-7.88) as did adjustment for infant diet (Table II). There
was a dose-response association between the number of food al-
lergies recorded and the frequency of vitamin D insufficiency
(more than 2 food allergies vs no food allergy: aOR, 10.48;
95% CI, 1.60-68.61). Among infants with both parents born in
Australia, vitamin D insufficiency was independently associated
with food allergy after adjusting for eczema, but not with eczema
after adjusting for food allergy (Table II).
We found no strong evidence of an association between food
allergy in the first year of life and any of the following: ambient
UVR levels at birth, season of birth, ambient UVR levels 6 weeks
prior to blood draw, and maternal use of vitamin D supplements
during pregnancy (Table III). However, there was some sugges-
tion of a threshold effect of low ambient UVR at birth, with in-
fants born in the lowest quintile having a small increase in odds
of food allergy compared with those in other quintiles (OR,
1.33; 95% CI, 0.99-1.80; P 5 .062).
Among infants who were food sensitized, vitamin D insuffi-
ciency was associated with increased odds of food allergy (Table
IV). This association was also evident in the substudy by using
skin color rather than country of birth stratification (data not
shown).To investigate the impact of missing data on food allergy status,
we conducted a sensitivity analysis that reclassified as ‘‘sensitized
and tolerant’’ those infants (n5 44) with vitamin D data available
who had at least 1 negative challenge to a food towhich they were
sensitized but had been excluded from the primary analysis as
they had not undergone challenge to all foods to which they were
sensitized (see Fig E1 for details). This did not substantially alter
any of the associations reported (data not shown).DISCUSSION
Infants of Australian-born parents with vitamin D insufficiency
were 3 times more likely to have egg allergy and 11 times more
likely to have peanut allergy, the odds increasing 10-fold among
those with 2 or more food allergies. Furthermore, among infants
who were food sensitized, those with vitamin D insufficiency
were 6 times more likely to be food allergic than tolerant. This is
the largest study to ascertain objectively food sensitization status
in an entire population-based sample,16 to use the gold standard
measure of food allergy status of all infants who were sensitized,
and to explore directly the association between serum vitamin D3
levels and challenge-proven food allergy status adjusting for a
wide range of potential confounders.
Akeyfindingwas the interactionbetweenvitaminDandparents’
country of birth. The differential effect of vitaminDon food allergy
depending on the parents’ country of birth may be related to skin
color or other unmeasured genetic, epigenetic, or environmental
variables.24 A recent study found a differential effect by genotype
of the risk of vitaminDdeficiency at birth and subsequent food sen-
sitization including an effect modification by CYP24A1, the gene
regulating the degradation of the active formof vitaminD3.
10Alter-
natively, migratory (eg, gastrointestinal microbial changes)25 or
cultural (eg, variation in lifestyle factors such as diet or vitamin
D supplementation in infancy at critical developmental windows)
influences may be important. In our substudy, infants of parents
born overseas were more likely to have received vitamin D supple-
mentation in early infancy (15.9% vs 8.4%). It is possible that
TABLE III. Association between season of birth, UVR, maternal vitamin D supplementation, and food allergy among infants with
both parents born in Australia
Nonallergic (n 5 2518) Food allergic (n 5 240*) ORy (95% CI) P value
Season of birth
Summer 91.5% 8.5% 1.0
Spring 92.0% 8.0% 0.94 (0.64-1.38) .74
Autumn 90.2% 9.8% 1.18 (0.80-1.72) .41
Winter 91.4% 8.6% 1.01 (0.69-1.48) .94
UVR at birth (quintiles)
<8.7 89.4% 10.6% 1.0
8.7-16.3 92.4% 7.6% 0.69 (0.46-1.05) .084
16.4-29.1 90.8% 9.2% 0.85 (0.59-1.23) .39
29.2-40.8 92.8% 7.2% 0.66 (0.43-1.01) .055
>40.8 91.6% 8.4% 0.77 (0.51-1.17) .22
UVR at recruitment/SPT (quintiles)
<7.9 89.7% 10.3% 1.0
7.9-15.7 92.7% 7.4% 0.69 (0.46-1.04) .077
15.8-28.5 90.2% 9.8% 0.95 (0.65-1.38) .79
28.6-40.0 91.9% 8.1% 0.76 (0.49-1.18) .22
>40.0 92.5% 7.5% 0.71 (0.47-1.07) .10
Maternal vitamin D supplements during pregnancy
None 92.0% 8.0% 1.0
Multivitamin 91.1% 8.9% 1.12 (0.77-1.62) .55
Additional vitamin D 88.4% 11.6% 1.50 (0.78-2.88) .22
*Defined as the average of ambient daily UVR for the month in which the child was born by using Australian Radiation Protection and Nuclear Safety Agency data for
Melbourne’s monthly average daily total UVR dose in standard erythemal doses from 2007 to 2012.
Adjustments for date of blood draw, current use of infant formula (classified as none, formula with continued breast-feeding, and formula alone), and history of egg consumption
(classified as none, baked goods containing egg, cooked egg on 1 occasion, and cooked egg on multiple occasions), age at OFC clinic attendance, sex, mothers’ country of birth (for
those born outside Australia), socioeconomic status, number of siblings, family history of allergy, maternal use of vitamin D supplements during pregnancy, dog ownership, and
maternal smoking did not change the estimates of the association of UVR at recruitment and food allergy and therefore the unadjusted estimate is provided.
This analysis includes 109 infants who were allergic to food not included in the serum vitamin D analysis, as they did not have blood samples tested for vitamin D levels.
TABLE IV. Association between vitamin D levels and food allergy among infants who were sensitized (positive SPT results)
stratified by parents’ country of birth
Parent’s country of birth
Vitamin
D (nmol/L)
Food allergic, n (%)
Odds of food allergy among infants who were sensitized
Unadjusted Adjusted*
No Yes OR (95% CI) P value OR (95% CI) P value
All infants (n 5 361) >50 59 (20.8) 225 (79.2) 1.0 1.0
<_50 6 (7.8) 71 (92.2) 3.10 (1.29-7.49) .012 3.40 (1.26-9.21) .016
Both born in Australia (n 5 186) >50 39 (26.9) 106 (73.1) 1.0 1.0
<_50 3 (7.3) 38 (92.7) 4.66 (1.36-15.97) .014 5.98 (1.44-24.79) .014
One or both born outside Australia (n 5 175) >50 20 (14.4) 119 (85.6) 1.0 1.0
<_50 3 (8.3) 33 (91.7) 1.85 (0.52-6.60) .34 1.99 (0.44-8.89) .37
*The adjusted analysis controlled for date of blood draw, current use of infant formula (classified as none, formula with continued breast-feeding, and formula alone), history of egg
consumption (classified as none, baked goods containing egg, cooked egg on 1 occasion, and cooked egg on multiple occasions), age at OFC clinic attendance, sex, and mothers’
country of birth (for those born outside Australia).
Difference in effect by parents’ country of birth in the adjusted model (P 5 .29).
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have protected them from food allergy earlier in the first year of
life, even though their measured vitaminD levels by age 12months
were low. This could lead to a spurious association between low vi-
taminD levels at age 12months and protection against food allergy
in infants of non–Australian-born parents.
A similar interaction between vitamin D and ethnicity has been
reported by Keet et al,27 who found that birth in autumn was as-
sociated with food allergy only among white children, although
they did not directly examine individual vitamin D levels. How-
ever, unlike Keet et al we found no evidence of an interaction be-
tween eczema and vitamin D levels, possibly reflecting the
differences in age groups studied (all participants in HealthNuts
were aged 1 year, while individuals who were allergic to foodin the study by Keet et al were aged up to 21 years). It is also pos-
sible that the interaction between season of birth and eczema on
food allergy could be related to factors other than vitamin D,
such as skin care practices (with regards to eczema management
and sun avoidance), in different countries.
Plausible mechanisms for the association between vitamin D
and food allergy include the lack of vitamin D induction of innate
epithelial defenses (such as cathelicidins) or dysregulation of
tight junction proteins,28 resulting in compromised intestinal bar-
rier function or vitamin D–mediated alteration of gastrointestinal
microbiota composition.2 The potential role of vitamin D in the
promotion of food tolerance among individuals who were sensi-
tized in our cohort may be explained by vitamin D’s capacity to
induce expression of IL-10-secreting regulatory T cells.29,30
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explained relatively little of the variation in serum vitamin D
levels compared with data from adult studies.31,32 Unsurprisingly,
therefore, these factors did not strongly predict the development
of food allergy in infants in the first year of life at the population
level, although there was modest evidence of a threshold effect of
low ambient UVR at birth. Although of borderline significance,
this is consistent with the findings of previous studies that have
used season and latitude as proxy measures for ambient UVR
and have suggested a link between food allergy and winter birth
and latitude.3-6 Personal UVR measures are required to minimize
the nondifferential misclassification of the exposure assessment
and evaluate this more thoroughly. Our failure to replicate previ-
ous studies of season of birth and increased risk of food allergy
may also be complicated by the presence of transient infantile
food allergy. Against this is the fact that vitamin D is more
strongly associated with both peanut allergy and multiple food al-
lergies (having more than 1 of the following: peanut, egg, or ses-
ame allergy) in our cohort—factors more closely associated with
persistence.33
It remains possible that atopy-related changes in behavior led
to a low vitamin D status, rather than the reverse. However, the
fact that most parents were as yet unaware of the food allergy
status of the infant at the time of the blood draw argues against
this. Furthermore, adjustment for other factors that would have
led to any behavioral changes such as family history did not
confound the association. Finally, the association between low
vitamin D levels and food allergy remained evident among the
parents who did not perceive their child to have a food allergy
prior to challenge (data not shown). Although the low uptake of
OFC among infants who were nonsensitized is a limitation, the
rich baseline data enabled backweighting to better reflect the
nonsensitized population. This backweighting increases the ex-
ternal validity of our findings. Parents may also have altered their
child’s diet because of other factors such as family history of food
allergy, colic, or reflux or because of apparent intolerance or
dislike of a food, which may be associated with food allergy.
However, we have measured infant dietary factors important for
vitamin D (consumption of egg, fish, and formula) and have
adjusted for these directly; thus, this is unlikely to explain our
findings. In Australia, although infant formula is fortified with
vitamin D, cow’s milk is not. Although there was a proportion of
eligible participants who did not participate in the study, whomay
have been less likely to have food allergy, it is unlikely that there
was also differential participation based on vitamin D levels as
this was not primarily a study of vitamin D and the hypothesis that
vitamin D may be associated with food allergy was not widely
known at the time the studywas conducted. In addition, thosewho
participate in research studies tend to be more likely to comply
with health guidelines (such as those recommending sun protec-
tion) and thus may have had lower vitamin D levels, leading to an
underestimate of the magnitude of the association between
vitamin D and food allergy.
Vitamin D insufficiency at age 12 months is associated with an
increased odds of food allergy among infants with Australian-
born parents, particularly among infants demonstrating allergic
sensitization. Randomized controlled trials stratified by genetic,
racial, or migratory status are required to determine whether the
correction of vitamin D status either prevents infantile food
allergy or promotes the development of tolerance in infants who
were allergic to food.We thank the children and parents who participated in the HealthNuts study
as well as the staff of Melbourne’s Local Government Areas for providing
access to community immunization clinics. We thank Nadine Bertalli for
formatting and proofing the document; ALK-Abello SA, Madrid, Spain, for
supplying the skin prick testing reagents; and theHealthNuts safety committee
comprising Associate Professor Noel Cranswick (Australian Paediatric Phar-
macology Research Unit, Murdoch Childrens Research Institute, Parkville,
Victoria, Australia), Dr Jo Smart (Department of Allergy and Immunology,
Royal Children’s Hospital, Melbourne, Victoria, Australia), and Associate
Professor Jo Douglass (Director, Department of Allergy and Immunology,
Royal Melbourne Hospital, Melbourne, Victoria, Australia).
Clinical implications: Vitamin D sufficiency may be an impor-
tant protective factor for food allergy in the first year of life.
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FIG E1. HealthNuts study participation and classification of food allergy status. *Note that some infants fell into more than 1 of these categories. Of these
infants, 44 had at least 1 negative challenge to a food to which they were sensitized; however, their full status was unknown as they did not undergo a
challenge to all foods to which they were sensitized. A sensitivity analysis was undertaken with these infants classified as ‘‘sensitized and tolerant’’ to


















































FIG E2. Distribution of vitamin D levels in HealthNuts serum samples by parents’ country of birth (n5 708).
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TABLE E1. Description of peanut, egg, and sesame oral food challenges
Food challenge type
Peanut Sesame Egg





Raw free range egg (Coles,
Glen Iris, Victoria, Australia)
Time between doses 20 min 20 min 15 min
Total dose 1.94 teaspoons (11.3 g),
contains ;2.6 g protein
9.7 mL (11.3 g),
contains ;2.9 g protein
Whole egg white from 1 large
egg (;58 g), contains ;4.5 g
protein
Amount given in each dose 1. Smear inside lip* 1. Drop inside lip* 1. Drop inside lip*
2. 1/16 tsp 2. 0.31 mL 2. 0.5 mL
3. 1/8 tsp 3. 0.62 mL 3. 1 mL
4. 1/4 tsp 4. 1.25 mL 4. 2 mL
5. 1/2 tsp 5. 2.5 mL 5. 5 mL
6. 1 tsp 6. 5 mL 6. 10 mL
7. – 7. – 7. Remainder of egg white
(usually 10-13 mL)
tsp, Tablespoon.
*Initial smear or drop inside the lip was administered without allowing contact with the outside of the lip. The initial dose was administered without mixing with other foods. All
subsequent doses were mixed with an age-appropriate previously tolerated food based on parental preference.
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of eczema Parents’ country of birth
Weight (inverse probability
of clinic attendance)
1 No No Australia 21
2 No Yes Australia 15
3 No No Other 43
4 No Yes Other 26
5 Yes No Australia 12
6 Yes No Other 24
7 Yes Yes Australia 5
8 Yes Yes Other 2
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TABLE E3. Differences between infants with and without blood samples available
Characteristic
Infants without
blood samples (n 5 417)
Infants with blood
samples (n 5 708)
P value for difference
(x2 test)
Family characteristics
Family history of eczema 38.5% 37.3% .71
Family history of food allergy 17.6% 15.8% .46
Both parents born in Australia 54.4% 54.6% .96
Maternal smoking during pregnancy 2.8% 3.1% .75
Maternal vitamin use during pregnancy
None 12.8% 16.9%
Multivitamin only 78.7% 77.2%
Additional vitamin D 8.5% 5.9% .074
Any siblings 42.8% 48.7% .054
Infant characteristics
Sex: male 49.6% 45.5% .18
Current eczema (at 12 mo) 41.7% 44.3% .46
History of eczema diagnosis
(by age 12 mo)
44.4% 48.7% .18
Ever breast-fed 97.3% 95.0% .075
Ever used infant formula 75.1% 78.0% .29
Ever consumed egg 91.7% 93.0% .44
Food allergic 54.2% 59.6% .11
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TABLE E4. Association between parent’s country of birth, skin color, and ethnicity in a substudy of 350 consecutive infants

















or Asia (n 5 37)
Maternal skin tone (%)
Dark 0.5 0 0 2.7 29.7
Olive 5.7 26.7 12.5 43.2 21.6
Olive/medium 18.2 33.3 25.0 13.5 10.8
Medium/fair 31.8 33.3 29.2 21.6 27.0
Fair 43.8 6.7 33.3 18.9 10.8
Infant skin tone (%)
Dark 0 3.1 0 0 21.6
Olive 1.6 25.0 6.3 16.2 18.9
Olive/medium 10.6 37.5 33.3 24.3 16.2
Medium/fair 40.8 28.1 35.4 37.8 27.0
Fair 47.1 6.3 25.0 21.6 16.2
Maternal ethnicity (%)
Caucasian 90.1 3.1 79.6 40.5 32.4
Asian 2.6 96.9 18.4 37.8 27.0
African 0 0 0 2.7 13.5
Aboriginal or Torres Strait Islander 0 0 0 0 0
Middle Eastern 0.5 0 2.0 2.7 10.8
Other 6.8 0 0 16.2 16.2
Paternal ethnicity (%)
Caucasian 95.7 3.1 61.7 81.1 45.9
Asian 1.6 96.9 25.5 10.8 29.7
African 0 0 0 0 10.8
Aboriginal or Torres Strait Islander 0.5 0 0 0 0
Middle Eastern 0.5 0 2.1 0 5.4
Other 1.5 0 10.6 18.1 8.1
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